Clinical evaluation of a real-time optoelectronic device in cervical cancer screening

CONCLUSION: TruScreen has the potential for screening high-grade cervical precancerous lesions and may replace cytological tests as a cervical cancer screening method in China to avoid subjectivity in the interpretation of cytological tests and requirements by pathologists.PMID:34625339 | DOI:10.1016/j.ejogrb.2021.09.027

Source: Reproductive Biology - October 9, 2021 Category: Reproduction Medicine Authors: Yingting Wei Wenjing Wang Mengxing Cheng Zubei Hong Liying Gu Jiaxin Niu Wen Di Lihua Qiu Source Type: research